Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Jun 5:2017:bcr2016218729.
doi: 10.1136/bcr-2016-218729.

Idiopathic hypogonadotropic hypogonadism reversal after testosterone replacement in a 34-year-old male

Affiliations
Case Reports

Idiopathic hypogonadotropic hypogonadism reversal after testosterone replacement in a 34-year-old male

Owais Rashid et al. BMJ Case Rep. .

Abstract

A 34-year-old male presented to the endocrinology clinic with the complaint of the absence of facial, axillary and pubic hairs. Further history revealed absent ejaculations and decreased early morning erections. The patient had no history of headaches, visual problems or anosmia. On physical examination, there were sparse facial, axillary and pubic hairs, bilateral gynaecomastia, stretch penile length of 5 cm and bilateral testicular volume of 10 mL. Laboratory investigations showed low luteinising hormone, follicular stimulating hormone and testosterone with normal prolactin and thyroid profile. MRI of the pituitary gland showed no evidence of pituitary microadenoma or macroadenoma. The patient was started on testosterone injections. After 9 months of testosterone replacement, the patient's testicular size increased to 20 mL bilaterally and his penile length increased to the mean adult size for his age with normal testosterone and luteinising hormone. He was, thus, advised to discontinue testosterone therapy.

Keywords: endocrinology; pituitary disorders.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
MRI of the pituitary gland showing no pituitary pathology. HPR, half-plane representation; LP, left posterior; MRI axis: RA, right anterior.

Similar articles

Cited by

References

    1. Silveira LF, Latronico AC. Approach to the patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab 2013;98:1781–8. 10.1210/jc.2012-3550 - DOI - PubMed
    1. Raivio T, Falardeau J, Dwyer A, et al. . Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med 2007;357:863–73. 10.1056/NEJMoa066494 - DOI - PubMed
    1. Medlineplus. Hypogonadotropic hypogonadism. 2016. https://medlineplus.gov/ency/article/000390.htm
    1. Delayed puberty — NEJM. New England Journal of Medicine 2016. http://www.nejm.org/doi/full/10.1056/nejmcp11092908
    1. Fraietta R, Zylberstejn DS, Esteves SC, et al. . Hypogonadotropic hypogonadism revisited. Clinics 2013;68(S1):81–8. 10.6061/clinics/2013(Sup01)09 - DOI - PMC - PubMed

Publication types

MeSH terms

Supplementary concepts